임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· Colorectal CancerA Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
협력: 아스트라제네카, 일라이 릴리
- 2상모집 예정· Osteoarthritis, KneeA Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
리드: 일라이 릴리
- 2상모집 예정· Chronic PainA Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
리드: 일라이 릴리
- 2상모집 예정· Waldenstrom MacroglobulinemiaMosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
협력: 일라이 릴리, 로슈
- 2상모집 예정· Prurigo Nodularis (PN)Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients
협력: 일라이 릴리
- 2상모집 중· Cognitive DysfunctionA Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
리드: 일라이 릴리
- 2상모집 중· Irritable Bowel SyndromeA Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
리드: 일라이 릴리
- 2상모집 중· Colitis, UlcerativeA Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
리드: 일라이 릴리
- 2상모집 중· Irritable Bowel SyndromeA Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
리드: 일라이 릴리
- 2상모집 중· Alopecia AreataA Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
리드: 일라이 릴리
- 2상모집 중· Acute PainA Study of LY4515100 in Participants With Pain Following Third Molar Removal
리드: 일라이 릴리
- 2상모집 중· Ulcerative Colitis (UC)LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
리드: 일라이 릴리
- 2상모집 중· Diabetic Peripheral Neuropathic PainA Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
리드: 일라이 릴리
- 2상모집 중· Opioid Use DisorderA Study of Brenipatide in Participants With Opioid Use Disorder
리드: 일라이 릴리
- 2상모집 중· Severe HypertriglyceridemiaA Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
리드: 일라이 릴리
- 2상모집 중· Bipolar DisorderA Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
리드: 일라이 릴리
- 2상모집 중· Grade 1 Follicular LymphomaPirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
협력: 일라이 릴리
- 2상모집 중· Waldenstrom MacroglobulinemiaA Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
협력: 애브비, 일라이 릴리
- 2상모집 중· Ulcerative ColitisLY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
리드: 일라이 릴리
- 2상모집 중단 (진행 중)· Diabetes Mellitus, Type 2A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
리드: 일라이 릴리
- 2상모집 중· Mantle Cell Lymphoma (MCL)Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma
협력: 일라이 릴리
- 2상모집 중· Obesity and OverweightEfficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
협력: 일라이 릴리
- 2상모집 중단 (진행 중)· Lymphoma, Non-HodgkinLong-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
리드: 일라이 릴리
- 2상모집 중· Chronic Lymphocytic LeukemiaClonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib
협력: 일라이 릴리
- 2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaPhase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
협력: 일라이 릴리, 리제네론
- 2상모집 중· Marginal Zone LymphomaPirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
협력: 일라이 릴리
- 2상모집 중단 (진행 중)· Mantle Cell LymphomaGATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
협력: 애브비, 일라이 릴리, 로슈
- 2상모집 중· Chronic Lymphocytic LeukemiaA Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
협력: 일라이 릴리
- 2상모집 중· Ulcerative ColitisA Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
리드: 일라이 릴리
- 2상모집 중· Mantle Cell LymphomaPhase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
협력: 일라이 릴리
- 2상모집 중· Differentiated Thyroid CancerSelpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
협력: 일라이 릴리
- 2상모집 중· Inflammatory Bowel DiseasesA Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
리드: 일라이 릴리
- 2상모집 중· Mantle Cell LymphomaGlofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
협력: 일라이 릴리, 로슈
- 2상모집 중· Chronic Lymphocytic LeukemiaFixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
협력: 일라이 릴리
- 2상모집 중· Triple Negative Breast NeoplasmsBicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
협력: 일라이 릴리
- 2상모집 중단 (진행 중)· Multiple SclerosisA Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
리드: 일라이 릴리
- 2상모집 중단 (진행 중)· Lichen Planus, OralEfficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
협력: 일라이 릴리
- 2상모집 중· Chronic Lymphocytic LeukemiaPhase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
협력: 일라이 릴리, 로슈
- 2상모집 중· Low Grade Serous Ovarian CarcinomaAbemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
협력: 일라이 릴리
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.